Skip to main content
. 2010 Jan 28;16(5):1781–1790. doi: 10.1089/ten.tea.2009.0482

FIG. 3.

FIG. 3.

(A) Equilibrium modulus and (B) dynamic modulus of the tissue-engineered constructs. (C) Glycosaminoglycan (GAG) content, (D) total collagen content, and (E) DNA content per construct (normalized to wet weight of the constructs). (F) Volume of the tissue-engineered constructs (normalized to the day 0 value). Type II collagen content of the constructs normalized to the wet weight (G) and total collagen (H) on day 56. *p < 0.005 versus FS; p < 0.05 versus all other groups; n = 4.

HHS Vulnerability Disclosure